Company Overview
NOVAVAX INC
NVAXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
1,123M
2025 FY
Net Income
440M
2025 FY
Shares Outstanding
162M
2025 FY
EPS
2.72USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1000694
Exchange
Nasdaq
Location
US